Sridhar Pennathur

Sridhar Pennathur has extensive work experience in the biopharmaceutical industry. Sridhar is currently serving as the Vice President of Analytical Development at Novavax Inc. Prior to this role, they held the position of Senior Director/Senior Fellow in Biopharmaceutical Development at AstraZeneca-Biologics. Sridhar also worked as the Senior Director in Global Technical Services at MedImmune LLC/AstraZeneca for a period of five years. Prior to joining MedImmune, Sridhar worked at Bristol Myers Squibb as a Senior Research Investigator. Their career in the industry began as a Post Doc at MGI Pharma. Overall, they have held several leadership positions and has a diverse range of experience in quality control, quality assurance, and technical services.

Sridhar Pennathur obtained a Ph.D. in Biochemistry from Buffalo State University, completing their studies between 1980 and 1985.